Search Results - "Heil, Emily"

Put the Fluoroquinolone Down and No One Gets Hurt by Heil, Emily L

Get full text

New Perspectives on Antimicrobial Agents: Cefiderocol by McCreary, Erin K, Heil, Emily L, Tamma, Pranita D

“…Bacterial resistance to carbapenem agents has reached alarming levels. Accordingly, collaborative efforts between national and international organizations and…”
Get full text

The Goldilocks Time for Remdesivir — Is Any Indication Just Right? by Heil, Emily L, Kottilil, Shyam

“…For 2 years, we have been under siege by a lingering global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In an ideal world,…”
Get full text

Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance by Strich, Jeffrey R, Heil, Emily L, Masur, Henry

“…Patients with sepsis present across a spectrum of infection sites and severity of illnesses requiring complex decision making at the bedside as to when prompt…”
Get full text

Toward More Rational Time-to-Antibiotic Metrics for Suspected Sepsis by Rhee, Chanu, Heil, Emily L.

Get full text

Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review by Phe, Kady, Heil, Emily L, Tam, Vincent H

“…Critically ill patients with sepsis or septic shock are at an increased risk of death. Early and aggressive interventions are essential for improving clinical…”
Get full text

Cefiderocol: the Trojan horse has arrived but will Troy fall? by Heil, Emily L, Tamma, Pranita D

“…Since other similar trials have not enrolled patients infected with carbapenem-resistant A baumannii, it seems unfair to compare cefiderocol's high mortality…”
Get full text

Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure by Rhee, Chanu, Chiotos, Kathleen, Cosgrove, Sara E, Heil, Emily L, Kadri, Sameer S, Kalil, Andre C, Gilbert, David N, Masur, Henry, Septimus, Edward J, Sweeney, Daniel A, Strich, Jeffrey R, Winslow, Dean L, Klompas, Michael

“…Abstract The Centers for Medicare & Medicaid Services’ Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) measure has appropriately established…”
Get full text

A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients by Kalaria, Shamir N, Gopalakrishnan, Mathangi, Heil, Emily L

“…The percentage of the time that the free drug concentration remains above a concentration threshold (% > concentration threshold) has frequently been…”
Get full text

Considerations for long-acting antiretroviral therapy in older persons with HIV by O'Shea, Jesse G, Cholli, Preetam, Heil, Emily L, Buchacz, Kate

“…People with HIV (PWH) can now enjoy longer, healthier lives due to safe and highly effective antiretroviral therapy (ART), and improved care and prevention…”
Get full text

What Is Left to Tackle in Inpatient Antimicrobial Stewardship Practice and Research by Bork, Jacqueline T., Heil, Emily L.

“…Despite widespread uptake of antimicrobial stewardship in acute care hospitals, there is ongoing need for innovation and optimization of ASPs. This article…”
Get full text

Probable hepatotoxicity from two second-generation integrase strand transfer inhibitors by Heil, Emily L., Pandit, Neha Sheth, Taylor, Gregory H.

Get full text

Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019 by Bork, Jacqueline T, Leekha, Surbhi, Claeys, Kimberly, Seung, Hyunuk, Tripoli, Megan, Amoroso, Anthony, Heil, Emily L

“…Interrupted time series segmented regression was conducted to trend antibiotic use and multidrug-resistant gram-negative (MDRGN) acquisition relative to…”
Get full text

Penicillin skin testing in methicillin-sensitive staphylococcus aureus bacteremia: A cost-effectiveness analysis by Mattingly, 2nd, T Joseph, Meninger, Stephen, Heil, Emily L

“…Beta-lactams are the mainstay for treating methicillin-susceptible Staphylococcus aureus (MSSA) infections complicated by bacteremia due to superior outcomes…”
Get full text

Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients by Heil, Emily L, Nicolau, David P, Farkas, Andras, Roberts, Jason A, Thom, Kerri A

“…This was a prospective study to determine if pharmacokinetic/pharmacodynamic (PK/PD)-based antibiotic dosing software aids in achieving concentration targets…”
Get full text

Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue Infections by Blackman, Alison L, Jarugula, Praneeth, Nicolau, David P, Chui, Sai Ho, Joshi, Manjari, Heil, Emily L, Gopalakrishnan, Mathangi

“…Linezolid standard dosing is fixed at 600 mg every 12 h (q12h) for adults. Literature suggests critically ill, obese patients require higher doses. The study…”
Get full text

In a Pinch: Cefiderocol for CRAB Infections by Karaba, Sara M, Hirsch, Elizabeth B, Heil, Emily L

“…Carbapenem-resistant Acinetobacter baumannii (CRAB) can cause significant infections with limited treatment options available. Falcone et al…”
Get full text

The Economics of Penicillin Allergy Testing: Still Scratching the Value Surface by Mattingly, T Joseph, Heil, Emily L

Get full text

It Is a Marathon, Not a Sprint—Sustainability of Stewardship in ICUs by Heil, Emily L., Bork, Jacqueline T.

Get full text

Erratum for Kalaria et al., "A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients" by Kalaria, Shamir N, Gopalakrishnan, Mathangi, Heil, Emily L

Get full text